Patents by Inventor Fredrick L. Minn

Fredrick L. Minn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6406716
    Abstract: The effectiveness of an anticonvulsant such as gabapentin for alleviating neuropathic pain is potentiated by a nontoxic antagonist for the N-methyl-D-aspartate receptor or nontoxic substance that blocks a major intracellular consequence of N-methyl-D-aspartate receptor activation.
    Type: Grant
    Filed: February 9, 2001
    Date of Patent: June 18, 2002
    Assignee: Endo Pharmaceuticals Inc.
    Inventors: Frank S. Caruso, Fredrick L. Minn, John W. Lyle
  • Publication number: 20010008889
    Abstract: The analgesic effectiveness of an tramadol is significantly enhanced by administering tramadol prior to, with or following the administration of an analgesia enhancer which is a nontoxic NMDA receptor blocker and/or a nontoxic substance that blocks at least one major intracellular consequence of NMDA receptor activation.
    Type: Application
    Filed: February 9, 2001
    Publication date: July 19, 2001
    Inventors: Frank S. Caruso, Fredrick L. Minn, John W. Lyle
  • Patent number: 6187338
    Abstract: The analgesic effectiveness of tramadol is significantly enhanced by administering tramadol prior to, with or following the administration of an analgesia enhancer which is a nontoxic NMDA receptor blocker and/or a nontoxic substance that blocks at least one major intracellular consequence of NMDA receptor activation.
    Type: Grant
    Filed: February 22, 1999
    Date of Patent: February 13, 2001
    Assignee: Algos Pharmaceutical Corporation
    Inventors: Frank S. Caruso, Fredrick L. Minn, John W. Lyle